IntergardRecalls & reported problems across all models
Intervascular Sas · 41 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 165
- Deaths reported
- 6
- Injuries reported
- 81
- Recalls
- 1
We found 41 models of Intergard by Intervascular Sas in the FDA's device registry (GUDID). Together they are named in 165 adverse event reports in the FDA's MAUDE database, received between Oct 12, 2015 and Sep 3, 2026 — classified as 6 deaths, 81 injuries, 78 malfunctions.
The most frequently reported specific device problem is “Manufacturing, Packaging or Shipping Problem” (57 reports).
1 FDA recall record name at least one of these models by its device identifier.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
Intergard recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Apr 29, 2022Terminated
Mislabeled: Product labeled as Intergard Woven Straight graft REF IGW0032-30, D: 8 mm, L: 30 cm, contained an Intergard Woven Straight graft of D: 32 mm and L: 30 cm
Z-1282-2022 · Root cause: Packaging process control · Recall details · FDA record ↗
Most reported Intergard problems
Device problems
- Manufacturing, Packaging or Shipping Problem57
- Product Quality Problem41
- Nonstandard Device15
- Insufficient Device Problem Information13
- Flaked10
- Moisture or Humidity Problem10
- Off-Label Use9
- Device Damaged Prior to Use6
Patient problems
- Blood Loss42
- No Clinical Signs, Symptoms or Conditions42
- Hemorrhage/Blood Loss/Bleeding35
- No Patient Involvement18
- No Consequences Or Impact To Patient12
- Ischemia Stroke4
- No Known Impact Or Consequence To Patient4
- Death3
Intergard models
41 models, most reported first. Each model has its own page with its reports, recalls and device details.
- Intergard IGW0032-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 recall2 reports
- Intergard HEWAA2810080810/1Prosthesis, Vascular Graft, Of 6mm And Greater Diameter12 reports
- Intergard HEWAA3010080810/1Prosthesis, Vascular Graft, Of 6mm And Greater Diameter12 reports
- Intergard HEWAA2610080810/1Prosthesis, Vascular Graft, Of 6mm And Greater Diameter2 deaths10 reports
- Intergard IGW0028-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter9 reports
- Intergard IGK1608Prosthesis, Vascular Graft, Of 6mm And Greater Diameter9 reports
- Intergard IGW0008-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter7 reports
- Intergard IGW0028-15Prosthesis, Vascular Graft, Of 6mm And Greater Diameter2 deaths7 reports
- Intergard IGK1407Prosthesis, Vascular Graft, Of 6mm And Greater Diameter7 reports
- Intergard IGK1809Prosthesis, Vascular Graft, Of 6mm And Greater Diameter7 reports
- Intergard IGK0008-40Prosthesis, Vascular Graft, Of 6mm And Greater Diameter7 reports
- Intergard HEWAA2410080810/1Prosthesis, Vascular Graft, Of 6mm And Greater Diameter7 reports
- Intergard IGW0030-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter5 reports
- Intergard IGK0008-70Prosthesis, Vascular Graft, Of 6mm And Greater Diameter5 reports
- Intergard IGK2010Prosthesis, Vascular Graft, Of 6mm And Greater Diameter5 reports
- Intergard IGK0008RS45Prosthesis, Vascular Graft, Of 6mm And Greater Diameter5 reports
- Intergard IGW0026-15Prosthesis, Vascular Graft, Of 6mm And Greater Diameter4 reports
- Intergard IGW0030-15Prosthesis, Vascular Graft, Of 6mm And Greater Diameter4 reports
- Intergard IGW0010-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter3 reports
- Intergard IGW0026-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter3 reports
- Intergard IGK0010-40Prosthesis, Vascular Graft, Of 6mm And Greater Diameter3 reports
- Intergard IGK1206Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 death3 reports
- Intergard IGKAX0808RS45/30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter3 reports
- Intergard IGKAX100808RS35/20Prosthesis, Vascular Graft, Of 6mm And Greater Diameter3 reports
- Intergard IGW0020-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter2 reports
- Intergard IGW0032-15Prosthesis, Vascular Graft, Of 6mm And Greater Diameter2 reports
- Intergard IGKUT0008-70Prosthesis, Vascular Graft, Of 6mm And Greater Diameter2 reports
- Intergard HEW3210BRIDGEProsthesis, Vascular Graft, Of 6mm And Greater Diameter2 reports
- Intergard IGK0008-20Prosthesis, Vascular Graft, Of 6mm And Greater Diameter2 reports
- Intergard HEWAA2010080810/1Prosthesis, Vascular Graft, Of 6mm And Greater Diameter2 reports
- Intergard IGW0018-15Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGW0022-30Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGK0006-70Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGK0016-40Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGK0018-40Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGK0007-70Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard HEW3010BRIDGEProsthesis, Vascular Graft, Of 6mm And Greater Diameter1 death1 report
- Intergard HEW2610BRIDGEProsthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGKUT0007-40Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGKUT0008-40Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
- Intergard IGK0020-40Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 report
Recent Intergard adverse event reports
The 15 most recent reports across all models, in the reporter's own words as published by the FDA.
InjurySep 3, 2026Leak/Splash
It was reported to Intervascular that during the surgical procedure, porosity of the graft was identified at several locations, resulting in bleeding from multiple positions. The bleeding stopped spontaneously and the patient is currently in good condition. The patient is well and stable.Complaint (b)(4).
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 50591580 ↗MalfunctionAug 7, 2026Product Quality Problem
Complaint #(b)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50173515 ↗MalfunctionAug 7, 2026Product Quality Problem
Complaint #(b)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50173358 ↗InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
THIS EVENT WAS COLLECTED AS PART OF THE INTERVASCULAR PMCF REGISTRY. PATIENT (B)(6) EXPERIENCED AN INTERGARD BYPASS GRAFT INFECTION ON (B)(6) 2016. THE ADVERSE EVENT WAS CATEGORIZED AS MAJOR ADVERSE LIMB EVENT (MALE) AND INFECTION RELATED TO THE DEVICE. A SURGICAL PROCEDURE WAS PERFORMED WITH GRAFT REINTERVENTION BUT WITH NO AMPUTATION. THE CLINIC NOTED THAT THIS AE WAS NOT RELATED TO PROCEDURE BUT RELATIONSHIP TO THE DEVICE WAS CAUSAL. THE CLINIC PROVIDED THE FOLLOWING DETAILS, "SINCE THE LAST FEMOROTIBIAL PROSTHETIC GRAFT INFECTION, THE PATIENT HAD A CHRONIC INFECTION MANAGED WITH DOXYCYCLINE SINCE 2017. HE WAS HOSPITALIZED ON (B)(6) 2019, FOR A CLINICAL PRESENTATION OF A MARKEDLY SWOLLEN, ERYTHEMATOUS RIGHT LEG WITH PURULENT DISCHARGE AT THE ANTERIOR FEMOROTIBIAL SURGICAL SITE. DUS DEMONSTRATED A PERIPROSTHETIC COLLECTION EXTENDING ALONG THE ENTIRE FEMOROTIBIAL BYPASS GRAFT. ON (B)(6) 2019, THE PATIENT UNDERWENT REPLACEMENT OF THE RIGHT ANTERIOR PROSTHETIC FEMOROTIBIAL BYPASS WITH AN ANTERIOR FEMOROTIBIAL BYPASS USING A VENOUS ALLOGRAFT. DURING THE SAME PROCEDURE, THE INFECTED INTERGARD ILIOFEMORAL PROFUNDA BYPASS WAS ALSO REPLACED WITH AN ILIOFEMORAL PROFUNDA BYPASS USING A VEN
Patient problems: Bacterial Infection
MAUDE report 25331188 ↗InjuryMay 29, 2026Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
THIS EVENT WAS COLLECTED AS PART OF THE INTERVASCULAR PMCF REGISTRY. PATIENT (B)(6) EXPERIENCED AN INTERGARD BYPASS GRAFT INFECTION ON 16DEC2016. THE ADVERSE EVENT WAS CATEGORIZED AS MAJOR ADVERSE LIMB EVENT (MALE) AND INFECTION RELATED TO THE DEVICE. A SURGICAL PROCEDURE WAS PERFORMED WITH GRAFT REINTERVENTION BUT WITH NO AMPUTATION. THE CLINIC NOTED THAT THIS AE WAS NOT RELATED TO PROCEDURE BUT RELATIONSHIP TO THE DEVICE WAS CAUSAL. THE CLINIC PROVIDED THE FOLLOWING DETAILS, "SINCE THE LAST FEMOROTIBIAL PROSTHETIC GRAFT INFECTION, THE PATIENT HAD A CHRONIC INFECTION MANAGED WITH DOXYCYCLINE SINCE 2017. HE WAS HOSPITALIZED ON (B)(6) 2019, FOR A CLINICAL PRESENTATION OF A MARKEDLY SWOLLEN, ERYTHEMATOUS RIGHT LEG WITH PURULENT DISCHARGE AT THE ANTERIOR FEMOROTIBIAL SURGICAL SITE. DUS DEMONSTRATED A PERIPROSTHETIC COLLECTION EXTENDING ALONG THE ENTIRE FEMOROTIBIAL BYPASS GRAFT. ON (B)(6) 2019, THE PATIENT UNDERWENT REPLACEMENT OF THE RIGHT ANTERIOR PROSTHETIC FEMOROTIBIAL BYPASS WITH AN ANTERIOR FEMOROTIBIAL BYPASS USING A VENOUS ALLOGRAFT. DURING THE SAME PROCEDURE, THE INFECTED INTERGARD ILIOFEMORAL PROFUNDA BYPASS WAS ALSO REPLACED WITH AN ILIOFEMORAL PROFUNDA BYPASS USING A VENOU
Patient problems: Bacterial Infection
MAUDE report 25330705 ↗MalfunctionApr 20, 2026Product Quality Problem
IT WAS REPORTED TO INTERVASCULAR THAT WHEN THE DOCTOR OPENED THE PACKAGE, HE FOUND THERE WAS YELLOW DOT ON THE SURFACE OF THE GRAFT. THEN HE USED ANOTHER NEW ONE TO COMPLETE THE SURGERY. COMPLAINT # (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24922656 ↗MalfunctionApr 20, 2026Product Quality Problem
IT WAS REPORTED TO INTERVASCULAR THAT WHEN THE DOCTOR OPENED THE PACKAGE, HE FOUND THERE WAS YELLOW DOT ON THE SURFACE OF THE GRAFT. THEN HE USED ANOTHER NEW ONE TO COMPLETE THE SURGERY. COMPLAINT # (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24922282 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, INTERMED HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24715127 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, INTERMED HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24714860 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, INTERMED HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24714692 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, INTERMED HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24714685 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, INTERMED HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24714672 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, INTERMED HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24714385 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, INTERMED HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24714259 ↗MalfunctionMar 30, 2026Moisture or Humidity Problem
IT WAS REPORTED TO INTERVASCULAR THAT THE CUSTOMER ALLEGED THAT HUMIDITY LEVELS WERE OVER 80% FOR MORE THAN 24 HOURS AND DID REACH 100%. THE DISTRIBUTOR, (B)(4) HAD ONE OF REPS VISIT THE CUSTOMER SITE FOR AN ON-SITE INSPECTION OF THE PRODUCTS. SOME PRODUCTS HAD BUBBLING ON THE LABELLING. IT WAS DESCRIBED THAT ALL PRODUCTS FELT COLD AS IF LIKE THEY WERE DEFROSTED. IT WAS SUSPECTED THAT THE PRODUCTS WERE EXPOSED TO EXTREMELY HIGH LEVELS OF MOISTURE. THE IMPACTED PRODUCTS INCLUDE 12 INTERVASCULAR HEMAGARD AND INTERGARD GRAFTS. TWELVE SEPARATE COMPLAINTS WERE CREATED FOR EACH AFFECTED PRODUCTS. ACCORDINGLY, TWELVE INDIVIDUAL EMDR SUBMISSIONS WILL BE SUBMITTED. THIS EMDR IS PART OF A SERIES OF TWELVE EMDRS SUBMITTED FOR THE SAME EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24714124 ↗
Other Intervascular Sas products
All Intervascular Sas devices →Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page